Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by stockbuphoonon Jul 07, 2019 9:41pm
84 Views
Post# 29894046

RE:RE:RE:i say next 2 weeks we have 1 NR

RE:RE:RE:i say next 2 weeks we have 1 NRWait, everyone was supposed to buy at 3 and 4 cents from your last weeks of posting? And it would never go below 1.5 cents? Never. But, watch the next few weeks if there is no deal announced. Will Thomson offer to buy us all out at 1 cent equiv or $10 after RS? We’ll see but PLI has delivered nothing in last $350M or 3 years. Not at all suspicious when chairman of board Best said they needed placebo trials to make a deal but sat back and watched PLI do nothing for the past 3 years after putting on their “expected in next 12 months” slides in 2016. Can you say orchestrated all the way down? Ryplazim CMC failure was contrived as anyone sensible would have used experienced consultants for protein biologic BLA CMC if it was at all important but it was not deemed important enough to spend $2-3M on CMC knowing that things would tank like they did with CRL letter. Pure evil.

pandorom999 wrote:


Ok, volumes will be light from now on, so it could be volatile....up or down,  but until we get the news it doesnt really matter because once one of the news hit, it will because of low # of shares available be very volatile...on the up side!  So at least initial trade could be easy +20/30% if shares are scarce (and depending on nature of deal)

Not knowing what kind of news we will get very short term  ( nasdaq ipo, lazard deal 1 and 2 ), it"s hard to price target....but one thing for sur, it can sky rocket if its good!

thats why i said to people that lost a lot to buy here, u are near the rights offering sp....it is worth it imo.

 



Bullboard Posts